Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11mg/kg/hr TXA intravenous infusion till the last suture----[1] 70
2Human Placenta-Derived Cells PDA001 Intravenous Infusion----[1] 96
3Intravenous Infusion----[1] 6
4Intravenous Infusion of Diclofenac Sodium[1] Diclofenac[3] D00903 ,
D00904 ,
D07816 		[2] PTGS1,
PTGS2 💬		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 78
5Intravenous infusion of MSCs----[1] 271
6Intravenous infusion of transduced cells----[1] 65
7Other: UC-MSCs by peripheral intravenous infusion[1] Human Umbilical Cord Mesenchymal Stem Cells---[1] 96